Safety and quality of life of peri-operative transdermal estradiol continuation during gender affirmation surgery in transgender women: a randomised placebo-controlled trial [ 1/1/2021 - 1/31/2023 ]

Research Grant

Brief description Despite no clear evidence, transgender women are told to stop their feminising estrogen treatment several weeks before gender surgery, but this causes severe 'menopausal symptoms' with hot flushes, depression and distress compounding an already stressful preparation for and recovery from major surgery. This trial will establish if continuing estrogen gel around the time of surgery is safe and effective at improving 'menopausal symptoms'.

Funding Amount $92,335

Funding Scheme Postgraduate Scholarships

Chief Investigator Dr Brendan Nolan

Notes Clinical Medicine and Science Research Scholarship